LAVA Medtech Debt To Equity vs. Earnings Per Share
| LVACDelisted Stock | USD 10.44 0.00 0.00% |
For LAVA Medtech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of LAVA Medtech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well LAVA Medtech Acquisition utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between LAVA Medtech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of LAVA Medtech Acquisition over time as well as its relative position and ranking within its peers.
LAVA |
LAVA Medtech Acquisition Earnings Per Share vs. Debt To Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining LAVA Medtech's current stock value. Our valuation model uses many indicators to compare LAVA Medtech value to that of its competitors to determine the firm's financial worth. LAVA Medtech Acquisition is currently regarded as number one stock in debt to equity category among its peers. It also is currently regarded as number one stock in earnings per share category among its peers creating about 0.06 of Earnings Per Share per Debt To Equity. The ratio of Debt To Equity to Earnings Per Share for LAVA Medtech Acquisition is roughly 15.88 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the LAVA Medtech's earnings, one of the primary drivers of an investment's value.LAVA Earnings Per Share vs. Debt To Equity
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
LAVA Medtech |
| = | 4.92 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
LAVA Medtech |
| = | 0.31 X |
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
LAVA Earnings Per Share Comparison
LAVA Medtech is currently under evaluation in earnings per share category among its peers.
LAVA Medtech Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in LAVA Medtech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, LAVA Medtech will eventually generate negative long term returns. The profitability progress is the general direction of LAVA Medtech's change in net profit over the period of time. It can combine multiple indicators of LAVA Medtech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
LAVA Medtech Acquisition Corp. does not have significant operations. LAVA Medtech Acquisition Corp. is a subsidiary of LAVA Medtech Sponsor LP. Lava Medtech is traded on NASDAQ Exchange in the United States.
LAVA Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on LAVA Medtech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of LAVA Medtech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the LAVA Medtech's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in LAVA Medtech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Use Investing Themes to Complement your LAVA Medtech position
In addition to having LAVA Medtech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Semiconductor Thematic Idea Now
Semiconductor
Companies involved in production of semiconductor and semiconductor materials. The Semiconductor theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Semiconductor Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in LAVA Stock
If you are still planning to invest in LAVA Medtech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LAVA Medtech's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |